Recording Now Available -- Webinar: Applications of iPS-Cell Derived Tissues in Safety Assessment

Webinar: Applications of iPS-Cell Derived Tissues in Safety Assessment

A recording is available of the webinar entitled "Applications of iPS-Cell Derived Tissues in Safety Assessment" featuring Dr. Kyle Kolaja, Vice President, Business Development, Cellular Dynamics International.

This webinar aired live on September 17, 2015, hosted by the American College of Toxicology in collaboration with the Teratology Society, British Toxicology Society, SOT Stem Cells Specialty Section, and Society of Toxicologic Pathology.

Abstract: The ability to make pluripotent stem cells from adult somatic cells has revolutionized cell biology, especially as access to differentiated tissues from induced pluripotent stem cells has improved. Differentiated cells from induced pluripotent cell are more similar to intact tissue than cell lines or primary culture and rodents thus have begun to change the standard models to more human in vitro based models. In this talk, numerous examples where stem cell derived tissues have replaced, refined, and/or reduced the reliance on animal models in drug screening, toxicology, and product safety are highlighted.

Click HERE to view the recorded webinar.

Webinar materials are property of the speaker and the American College of Toxicology and are intended for use by the host society and cohost societies' members for educational purposes only. Any distribution or copy of the materials is prohibited. By downloading from the link provided you agree to the terms expressed above.

 

Recent Stories
Announcing the New Teratology Society Innovator Award

FDA Launches Predictive Toxicology Roadmap

PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus